These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 3663814)

  • 1. The analysis of multiple endpoints in clinical trials.
    Pocock SJ; Geller NL; Tsiatis AA
    Biometrics; 1987 Sep; 43(3):487-98. PubMed ID: 3663814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the design and analysis of randomized clinical trials with multiple endpoints.
    Tang DI; Geller NL; Pocock SJ
    Biometrics; 1993 Mar; 49(1):23-30. PubMed ID: 8513104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical tests based on new composite hypotheses in clinical trials reflecting the relative clinical importance of multiple endpoints quantitatively.
    Nishikawa M; Tango T; Ohtaki M
    Biom J; 2009 Oct; 51(5):749-62. PubMed ID: 19777463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate.
    Lehmacher W; Wassmer G; Reitmeir P
    Biometrics; 1991 Jun; 47(2):511-21. PubMed ID: 1912258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating co-primary endpoints collectively in clinical trials.
    Li QH
    Biom J; 2009 Feb; 51(1):137-45. PubMed ID: 19219905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A note on one-sided tests with multiple endpoints.
    Perlman MD; Wu L
    Biometrics; 2004 Mar; 60(1):276-9; discussion 279-80. PubMed ID: 15032799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gatekeeping testing via adaptive alpha allocation.
    Li JD; Mehrotra DV
    Biom J; 2008 Oct; 50(5):704-15. PubMed ID: 18932133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A note on the power of Fisher's least significant difference procedure.
    Meier U
    Pharm Stat; 2006; 5(4):253-63. PubMed ID: 17128424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Dunnett-Bonferroni-based parallel gatekeeping procedure for dose-response clinical trials with multiple endpoints.
    Xu H; Nuamah I; Liu J; Lim P; Sampson A
    Pharm Stat; 2009; 8(4):301-16. PubMed ID: 19065544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procedures for comparing samples with multiple endpoints.
    O'Brien PC
    Biometrics; 1984 Dec; 40(4):1079-87. PubMed ID: 6534410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A generalized estimating equation approach for modeling random length binary vector data.
    Albert PS; Follmann DA; Barnhart HX
    Biometrics; 1997 Sep; 53(3):1116-24. PubMed ID: 9290230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.
    Zhao Y; Grambsch PM; Neaton JD
    Clin Trials; 2007; 4(2):140-53. PubMed ID: 17456513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplicity adjustment for multiple endpoints in clinical trials with multiple doses of an active treatment.
    Quan H; Luo X; Capizzi T
    Stat Med; 2005 Jul; 24(14):2151-70. PubMed ID: 15909290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to deal with multiple endpoints in clinical trials.
    Neuhäuser M
    Fundam Clin Pharmacol; 2006 Dec; 20(6):515-23. PubMed ID: 17109645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A graphical approach to sequentially rejective multiple test procedures.
    Bretz F; Maurer W; Brannath W; Posch M
    Stat Med; 2009 Feb; 28(4):586-604. PubMed ID: 19051220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Method of balanced adjustment in testing co-primary endpoints.
    Kordzakhia G; Siddiqui O; Huque MF
    Stat Med; 2010 Aug; 29(19):2055-66. PubMed ID: 20683896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of multiplicity adjustment strategies for correlated binary endpoints.
    Leon AC; Heo M
    J Biopharm Stat; 2005; 15(5):839-55. PubMed ID: 16080237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bonferroni-based correction factor for multiple, correlated endpoints.
    Shi Q; Pavey ES; Carter RE
    Pharm Stat; 2012; 11(4):300-9. PubMed ID: 22588983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A reviewer's perspective on multiple endpoint issues in clinical trials.
    Huque MF; Sankoh AJ
    J Biopharm Stat; 1997 Nov; 7(4):545-64. PubMed ID: 9358328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An efficient method for accommodating potentially underpowered primary endpoints.
    Li J; Mehrotra DV
    Stat Med; 2008 Nov; 27(26):5377-91. PubMed ID: 18759248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.